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Abstract 
 Background and objectives: angiotensin II is involved in the 
development of hypertension. The main objectives of the study were to 
measure and compare the levels of angiotensin II among normal population in 
various areas with different altitudes Methods: Study design: cross- sectional 
study was conducted to collect data from participants at the same time. Study 
setting: participants from various areas with different altitudes were recruited 
to participate in this study. A total of 1500 participants were included. Study 
procedure: data was collected from participants based on a questionnaire that 
was constructed for this study. Blood samples were withdrawn from 
participants by a well- trained nurse. Angiotensin II was measured using 
enzyme linked immune sorbent assay (ELISA). Statistical analysis: data was 
analyzed using SPSS version 20. Data was represented as means, standard 
deviations, frequencies and percentage. The relationship between variables 
was tested using independent T-Test. The significance was considered at p 
value <0.05. Results: the level of angiotensin II was 8.84± 4.65 pg/ml in Dead 
Sea, 11.21± 6.05 pg/ml in Sea level, and 12.08± 5.19 pg/ml in Ajloun. There 
was a significant difference between the means of angiotensin II between 
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Ajloun and Dead Sea (p=0.039). no other significant differences were 
observed between the study areas. Conclusion: the angiotensin II varies 
between the areas according to their altitudes and this consideration should be 
taken into account when hypertensive drugs are prescribed. 
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Introduction  
Angiotensin is an oligopeptide in the blood that causes 
vasoconstriction, increased blood pressure, and release of aldosterone from the 
adrenal cortex. It is derived from the precursor molecule angiotensinogen, a 
serum globulin produced in the liver and it plays an important role in the renin-
angiotensin-aldosterone system. Angiotensin was independently isolated in 
Indianapolis and Argentina in the late 1930s (as 'Angiotonin' and 'Hypertensin' 
respectively) and subsequently characterized and synthesized by groups at the 
Cleveland Clinic and Ciba laboratories in Basel, Switzerland (Basso and 
Terragno, 2001).  
Angiotensinogen is an α-2-globulin that is produced constitutively and 
released into the circulation mainly by the liver (Skurk et al, 2001). It is a 
member of the serpin (serine protease inhibitor)-family of proteins in blood 
interacts with and inhibits other enzymes of the blood coagulation system 
(Devlin, 2006), although it is not known to inhibit other enzymes, unlike most 
serpins. Plasma angiotensinogen levels are increased by plasma corticosteroid, 
estrogen, thyroid hormone, and angiotensin II levels. Angiotensinogen is also 
known as renin substrate. Human angiotensinogen is 452 amino acids long, 
but other species have angiotensinogen of varying sizes (Basso and Terragno, 
2001).  
Angiotensin I is formed by the action of renin on angiotensinogen. 
Renin cleaves the peptide bond between the leucine (Leu) and valine (Val) 
residues on angiotensinogen, creating the ten amino acid peptide, angiotensin 
I.  
Angiotensin I appears to have no biological activity and exists solely 
as a precursor to angiotensin II (Carson et al., 1999). Angiotensin I is 
converted to angiotensin II through removal of two terminal residues by the 
enzyme Angiotensin-converting enzyme (ACE), which is found predominantly 
in the capillaries of the lungs (Skurk et al., 2001). ACE is actually found all 
over the body, but it has its highest density in the lung. Angiotensin II acts as 
an endocrine, autocrine/ paracrine, and intracrine hormone (Lees et al., 1993). 
 
Angiotensin II  
It is a potent direct vasoconstrictor that constricts arteries and veins 
and increases blood pressure by increasing blood volume and peripheral 
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resistance (Ardaillou, 1997).It increases thirst sensation through the 
subfornical organ of the brain, decreases the response of the baroreceptor 
reflex, and increases the desire for salt. It increases secretion of ADH in the 
posterior pituitary and secretion of ACTH in the anterior pituitary. It also 
potentiates the release of norepinephrine by direct action on postganglionic 
sympathetic fibers (Berry et al., 2002).  
Angiotensin II acts on the adrenal cortex, causing it to release 
aldosterone, a hormone that causes the kidneys to retain sodium and lose 
potassium (Hall, 2003).  
Angiotensin II causes constriction of the efferent renal arterioles, 
which has two effects on peritubular capillary dynamics that raise sodium and 
water reabsorption. First, efferent arteriolar constriction reduces peritubular 
capillary hydrostatic pressure. Second, efferent arteriolar constriction reduces 
renal blood flow, raises filtration fraction in the glomerulus and increases the 
concentration of proteins and colloid osmotic pressure in the peritubular 
capillaries. This leads to an increase in the reabsorptive force at the peritubular 
capillaries and raises tubular reabsorption of sodium and water. Angiotensin 
II directly stimulates sodium reabsorption in the proximal tubules, in the loops 
of Henle, in the distal tubules, and in the collecting tubules (Guyton, Hall, 
2006).  
Parati et al (2014) studied the level of angiotensin II and blood pressure 
in high altitude areas taking into consideration that little information is 
available about ambulatory blood pressure (ABP) variations and the efficacy 
of antihypertensive drugs under such conditions. Moreover, the authors 
expressed their views that there is a deficiency of information about the 
efficacy of angiotensin receptor blockers under these condition. Findings of 
their study showed that both blood pressure and angiotensin II were increased 
with high altitudes and that the blockage of angiotensin receptor II helped in 
maintaining blood pressure. 
 
Our study aimed to measure and compare the levels of angiotensin 
II among normal population in various areas with different attitudes. 
 
Methods and subjects  
Study design  
Cross sectional design was conducted in three areas: the Dead Sea (400 
meters below the Sea level), the Sea level area and Ajloun area (1200 meters 
above the Sea level), Jordan.  
The study sample included a total of 1500 participants of them 500 
participants were included from each area. All participants were males, 
matched for age grouping, and they were apparently healthy.  
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Data collection  
The data for each participant was collected and tabulated. Data 
included study variables such as blood pressure, weight, height, waist 
circumference, heart rate per minute, the level of angiotensin II, and packed 
cell volume (PCV).  
 
Study procedure  
The following measurements were taken: blood pressure for all 
participants was measured using sphygmomanometer with a stethoscope. 
Height was measured using 2 metric scaled rulers fixed to the wall of the room. 
Weight was measured using a well calibrated scale. Waist circumference was 
measured using a manual metric scale in centimeters. Heart rate was measured 
through radial pulse from the left hand for full minute, while the subjects were 
at rest. Angiotensin II was measured using enzyme linked immunosorbent 
assay (ELISA).  
 
Data analysis  
The analysis of data was carried out using SPSS version 20. All data 
were included and represented as mean and standard deviation. The relations 
between variables were computed using independent T test. Significance was 
considered at p value <0.05. 
 
Results  
General characteristics of participants  
As seen in table 1, age was within the similar pattern in study areas in 
which it was 17.6 years in both Dead sea level and Sea level, and slightly 
higher in Ajloun (17.83 years). Weight (kg) was also following similar 
distribution in study areas (67.31 kg-67.69 kg). The height (cm) was also 
observed within similar patterns and this pattern was observed for the 
remaining variables included in table 1. 
Table 1: General characteristics of participants 
variables Dead sea level Sea level Ajloun 
Age 17.6 17.6 17.83 
Wt/kg 67.31 67.69 67.37 
Ht/cm 169.29 170.5 169.51 
BMI 23.45 23.26 23.42 
Waist/cm 76.37 76.38 75.99 
SBP/mmHg 122.42 118.07 125.74 
DBP/mmHg 76.31 75.74 79.62 
MBP/mmHg 91.64 89.84 94.95 
Pulse/min 79.74 79.07 81.71 
PCV 42.17   41.50   45.27  
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Figure1: Comparison between the means of variables Affecting Blood Pressure. 
 
The level of Angiotensin II in study areas  
As it can be seen in from table 2, the level of angiotensin II is 8.84± 
4.65 pg/ml in Dead Sea, 11.21± 6.05 pg/ml in Sea level, and 12.08± 5.19 pg/ml 
in Ajloun. When the significance was tested using independent T test, there 
was a significant difference between the means of angiotensin II between 
Ajloun and Dead Sea (p=0.039). no other significant differences were 
observed between the study areas.  
Table 2: Comparison between Angiotensin II Concentration (pg/ml) in study áreas 
P value Mean ± std Target Area Mean ± std Target Area 
0.129 11.21± 6.05 Sea level 8.84  ±  4.65 Dead Sea  
0.039 8.84  ±  4.65 Dead Sea 12.08 ± 5.19 Ajloun 
0.571 12.08 ± 5.19 Ajloun 11.21± 6.05 Sea level 
 
Discussion  
Blood pressure is the main force for the hemodynamics that keeps 
continuous blood flow for all the body tissues which is essential for 
homeostasis. It is well known that blood pressure is regulated by two factors: 
first factor is the peripheral resistance which mainly depends on the elasticity 
of arterial system, mainly the arterioles, which determines the radius of these 
arteries and the influence of sympathetic activity through the baroreceptors 
during transient change of blood pressure. Also the level of the angiotensin 
hormone significantly can change the diameter of arterioles i.e. the peripheral 
resistance.  
The second factor which regulates blood pressure is the blood volume 
which is mainly regulated by the level of rennin-angiotensin system that starts 
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mainly from the kidney. So any condition that decreases or increases the level 
of blood pressure will be antagonized by changing the level of angiotensin.  
The first line to change the radius is the vasoconstriction. It is the 
presence of oxygen that can cause vasoconstriction and hypoxia causes 
vasodilatation and this oxygen availability is different at different levels of 
altitude i.e. hypoxia at high altitude and high oxygen concentration at low 
altitude.  
The results of the present study showed that among subjects who are 
within similar patterns of demographic characteristics, there were slight 
variations in blood pressure parameters. The age of participants was 
approximately 17 years, the age at which no hypertension is expected to occur 
to examine the effect of altitude on the angiotensin II level.  
The concentration of angiotensin II, a hormone which is involved in 
the long-term regulation of blood pressure, was the highest at high altitude and 
it declined as we went down to the Dead Sea area (p value ≤ 0.05). This implies 
the effect of altitude on the level of angiotensin II. The highest level of 
angiotensin II was in Ajloun 12.08 pg/ml (the area with the highest altitude), 
and the lowest level was in the Dead sea 8.84 pg/ml. The difference in means 
among the participants was statistically significant (p=0.039). Up to the best 
knowledge of authors, this is the first study in Jordan that measures the level 
of angiotensin among population from various areas with different altitudes.  
The data of our results agree with the study of Parati et al (2014) who 
reported increased blood pressure and angiotensin II among participants in 
high altitude areas and they confirmed their results through blocking of 
angiotensin receptor to maintain blood pressure.  
 
Conclusion 
The present study reflected changes in the level of angiotensin II with 
high altitude areas and this factor should be taken into account when anti-
hypertensive drugs have to be selected. 
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